This Biotech Is Up 194% in a Year but One Investor Took Millions Off the Table

Oregon-based Stonepine Capital Management reported a sale of 250,000 shares of Indivior PLC (NASDAQ:INDV), reducing its position by approximately $2.75 million, according to a November 13 SEC filing.According to a Securities and Exchange Commission (SEC) filing dated November 13, Stonepine Capital Management sold 250,000 shares of Indivior PLC (NASDAQ:INDV) during the third quarter. The transaction led to a decrease in the fund’s position value by approximately $2.75 million, bringing its Indivior holding to 100,000 shares worth $2.41 million at quarter-end.Stonepine's Indivior position now represents 1.96% of reportable AUM, down from 5.06% the previous quarter.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool